| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/05/2007 | CN101081222A Novel medicine use of indirubin derivates |
| 12/05/2007 | CN101081221A Use of dihydro myricetin in the preparing of medicine |
| 12/05/2007 | CN101081220A Angiocardiopathy treating traditional Chinese medicine and the preparing technology thereof |
| 12/05/2007 | CN101081219A Composition containing taxane genus compound, the method for preparing the same and the use thereof |
| 12/05/2007 | CN101081217A Slow-release small pill prparation containing huperzine A and method for making same |
| 12/05/2007 | CN101081216A Carbostyrile genus antibiotic preparation took orally |
| 12/05/2007 | CN101081214A Methodc for preparing sub-micron gemfibrozil medicament powder |
| 12/05/2007 | CN101081213A Butane diacid(5-androstene-17-ketone- 3beta -hydroxyl group ) diester solid dispersoid and method for making same and applications thereof |
| 12/05/2007 | CN101081212A Protease inhibitors liposomes aerosol |
| 12/05/2007 | CN101081211A Water indissoluble carbostyrile compound injection and method for preparing the same |
| 12/05/2007 | CN101081210A Carbostyrile antibiotic injection preparations |
| 12/05/2007 | CN101081209A Anticancer composition containing tyrosine kinase restraining agent and taxane |
| 12/05/2007 | CN101081208A Slow-release injection containing tyrosine kinase restraining agent and platinum compound |
| 12/05/2007 | CN101081205A Instant jelly glue for eyes |
| 12/05/2007 | CN101081204A Method for preparation of cross-linking hyaluronic acid sodium jelly glue implanted in eyes |
| 12/05/2007 | CN101081203A Method of increasing testosterone and related steroid concentrations in women |
| 12/05/2007 | CN100352923C Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 12/05/2007 | CN100352921C Compositions and methods for identifying antigens which elicit an immune response |
| 12/05/2007 | CN100352918C Cellular immunogenicity potentiating composition containing alpha-glycosylceramide |
| 12/05/2007 | CN100352889C Composition containing high oxygen stabilized double bonded organic compound |
| 12/05/2007 | CN100352831C Burnet general saponin extract , its preparation method and use |
| 12/05/2007 | CN100352825C Extractive form active ingredient of bitter bamboo, prepartion method and application |
| 12/05/2007 | CN100352820C Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans |
| 12/05/2007 | CN100352819C Novel compounds as NS3-serine protease inhibitors of hepatitis c virus |
| 12/05/2007 | CN100352817C Pyridinoylpiperidines as 5-HTLF agonists |
| 12/05/2007 | CN100352816C Nociceptin analogs |
| 12/05/2007 | CN100352810C Fumagillol derivatives and processes for preparing the same |
| 12/05/2007 | CN100352809C Aminophenylbenzothiazole compounds |
| 12/05/2007 | CN100352807C Chemical compounds |
| 12/05/2007 | CN100352806C 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists |
| 12/05/2007 | CN100352804C 酰胺衍生物 Amide derivatives |
| 12/05/2007 | CN100352510C Therapeutically useful triethyleneglycol cholesteryl oligonucleotides |
| 12/05/2007 | CN100352509C Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
| 12/05/2007 | CN100352507C Osmotic pump controlled release formulation containing two active constituents of medicine and process for preparing the same |
| 12/05/2007 | CN100352506C Co-therapy for the treatment of migraine comprising anticonvulsant derivatives and anti-migraine agents |
| 12/05/2007 | CN100352505C A combination of FBPase Inhibitors and insulin sensitizers for the treatment of diabetes |
| 12/05/2007 | CN100352504C Nutritious supplementing agent contg. a-glucosidase inhibitor and a-amylase inhibitor |
| 12/05/2007 | CN100352503C Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug |
| 12/05/2007 | CN100352498C Three dimensional eye patch for treating eye wrinkles an its preparation method |
| 12/05/2007 | CN100352476C Weichangyanping capsule for treating gastroenteritis |
| 12/05/2007 | CN100352462C Rhinitis treating ointment |
| 12/05/2007 | CN100352461C External-use medicine for treating leucoderma and its preparing method |
| 12/05/2007 | CN100352458C Preparaton of banlangen and method for controlling quality |
| 12/05/2007 | CN100352455C Ginkgo Damo freeze-drying prepn. and its prepn. method |
| 12/05/2007 | CN100352453C Refined extractive of cassah silkworm and preparation method |
| 12/05/2007 | CN100352449C Medicament composition for treating tinea pedis and tinea corporis |
| 12/05/2007 | CN100352448C Methods and compositions for the prevention of tolerance to medications |
| 12/05/2007 | CN100352447C Anxiolytic matter extracted from preparata |
| 12/05/2007 | CN100352446C Medicinal compositions comprising n-(3-chloro-1h-indol-7-yl)-4-sulfamoylbenzenesulfonamide and further cytostatics |
| 12/05/2007 | CN100352445C A method of treating human skin and a skin care composition for use in such a method |
| 12/05/2007 | CN100352444C A process for the preparation of piroxicam: beta-cyclodextrin inclusion compounds |
| 12/05/2007 | CN100352443C Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist |
| 12/05/2007 | CN100352442C Pharmaceutical combinations |
| 12/05/2007 | CN100352441C Combination therapy for the treatment of cancer |
| 12/05/2007 | CN100352440C Orally dispersible pharmaceutical piribedil composition |
| 12/05/2007 | CN100352439C Compound nicotinic acid slow releasing capsule and its preparing method |
| 12/05/2007 | CN100352438C Milrione lyophilied powder injection and its preparing method |
| 12/05/2007 | CN100352437C Piperazine derivatives, their preparation and their use for treating central nervous system (CNS) disorders |
| 12/05/2007 | CN100352436C Oral suspension of tegaserod |
| 12/05/2007 | CN100352435C Dry syrup preparation of procaterol comprising ascorbinic acid and citric acid |
| 12/05/2007 | CN100352434C 组合物 The composition |
| 12/05/2007 | CN100352433C Fatty alcohols and fatty acid esters useful for treatment of inflammation |
| 12/05/2007 | CN100352432C Nateglinide-containing preparation |
| 12/05/2007 | CN100352431C Pharmaceutical salts |
| 12/05/2007 | CN100352430C Self microemulsifying preparation of curcumin and its preparing process |
| 12/05/2007 | CN100352428C Capsule containing ginkgo leaf extract |
| 12/05/2007 | CN100352426C Method for preparing polymer micelle pharmaceutical preparation containing drug for injection |
| 12/05/2007 | CN100352420C Dendrite elongation inhibitor for melanocyte and skin preparation for external use containing the same |
| 12/05/2007 | CN100352373C Health-care food Lingchong crusta-amine for improving user's immunity and its prepn. method |
| 12/05/2007 | CN100352358C Method for preparing liver-benefiting, face-beautifying milk liquid with micron pine pollen, pearl powder for women |
| 12/05/2007 | CN100352349C Anhydrous silver dihydrogen citrate compositions |
| 12/04/2007 | US7304186 Synthetic method and novel chemical compounds |
| 12/04/2007 | US7304171 Compounds and methods for cytoprotection |
| 12/04/2007 | US7304167 Biphenylcarboxamides useful as lipid lowering agents |
| 12/04/2007 | US7304166 (2S,4S)-2-Cyano-4-fluoro-1-[(2-hydroxy-1,1-dimethyl)ethylamino]acetylpyrrolidine benzenesulfonate; dipeptidyl peptidase IV inhibitors with high-purity uniform crystal form and excellent solid-state stability |
| 12/04/2007 | US7304162 Regulating and tailoring expression levels; such as N-[3-(4-chloro-phenyl)-5,5-dimethyl-[1,2,4]oxadiazol-4-yl]-3-ethyl-benzamide |
| 12/04/2007 | US7304158 Cyclizing 2,6-diaminopyridine in sulfuric acid with malic acid to form 2-amino-7-hydroxy-1,8-naphthyridine; phthalimidating the naphthyridine and replacing the OH with Cl; reducing the product to form the hydroxyindolinone derivative and etherifying with 5-methyl-2-oxo-hexyltriphenylphosphonium halide |
| 12/04/2007 | US7304156 Preparation of aminopyrimidine compounds |
| 12/04/2007 | US7304155 Nonsteroid; enantiomers are selective antagonists of the estrogen beta receptor relative to the alpha receptor; tissue selectivity; fewer estrogen-related side effects; menopause, osteoporosis, hormone replacent therapy, contraceptive, endometriosis; 10-aminoalkyloxyphenyl benzo[b]fluorene 2,8-diols |
| 12/04/2007 | US7304094 Alzheimer's disease, modulate the processing of amyloid precursor protein by gamma-secretase |
| 12/04/2007 | US7304093 Ketone compounds and compositions for cholesterol management and related uses |
| 12/04/2007 | US7304092 Psoriasis, genital warts and hyperproliferative cell growth diseases, including hyperproliferative keratinocyte diseases such as hyperkeratosis, ichthyosis, acetylene derivatives |
| 12/04/2007 | US7304091 Statin-like compounds |
| 12/04/2007 | US7304090 Using fluorescein; polycystic kidney disease, diarrhea, antiarrhythmia agents, antitumor agents, contraceptice |
| 12/04/2007 | US7304089 Preparation for improved dietary utilisation |
| 12/04/2007 | US7304088 Peptide like compounds for treating coronavirus or hepatitis C virus; severe acute respiratory distress syndrome |
| 12/04/2007 | US7304087 1-acyl-pyrrolidine derivatives for the treatment of viral infections |
| 12/04/2007 | US7304086 Inhibitors of glutaminyl cyclase |
| 12/04/2007 | US7304085 Nitrogen-containing heteroaryl derivatives |
| 12/04/2007 | US7304083 2-iminoimidazole derivatives (2) |
| 12/04/2007 | US7304082 5-Anilino- or phenylalkylamino-3-furanylalkyl-4H-1,2,4-triazoles (ethyl 5-(5-phenylamino-4H-[1,2,4]triazol-3-ylsulfanylmethyl)-furan-2-carboxylate); type 2 methionine aminopeptidase inhibitors; antiproliferative agents |
| 12/04/2007 | US7304081 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: 1'-{[1-(4-Chlorophenyl)cyclo-pentyl]carbonyl}-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents |
| 12/04/2007 | US7304080 Substituted 1,2,4-oxadiazoles, compositions and methods of use |
| 12/04/2007 | US7304079 Preparing 3-benzothiazolylalkyl-1-indolylacetic acids and esters by cyclizing a 3-(anilinothiocarbonylalkyl)-1-indolylacetic ester with potassium ferricyanide or sodium hydride, optionally deprotecting the acid group; aldose reductase inhibitors for diabetic complications; side effect reduction |
| 12/04/2007 | US7304078 Thrombosis; cardiovascular disorders; restenosis; hypotensive agents; antiarrhythmia agents; antiinflamamtroy agents; central nervous system disorders |
| 12/04/2007 | US7304077 Asthma, rhinitis therapy |
| 12/04/2007 | US7304076 Dietetics; antidiabetic agents; eating disorders |
| 12/04/2007 | US7304075 Aqueous solution of sitafloxacin and sodium chloride; photostable microorganisms |
| 12/04/2007 | US7304074 Aminoimidazlinones and aminothiazolinones: 6-[2-(2,4-Bis-trifluoromethyl-benzylamino)-5-oxo-3,5-dihydro-imidazol-4-ylidenemethyl]-4-isopropoxy-[1,5]naphthyridine-3-carbonitrile; inhibit cyclin-dependent kinase 1 and are selective against Cdk2 and Cdk4; control of breast, lung, colon and prostate tumors |
| 12/04/2007 | US7304073 Administering a dihydrophenanthridinesulfonamide: N-(8-fluoro-6-methyl-5,6-dihydro-5-phenanthridinyl)-p-hydroxybenzenesulfonamide; interaction with estrogen receptor ER-alpha and/or -beta with no creatine kinase stimulation and without uterotropic activity |